Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Review Article
Henipavirus Vaccine Development
Jackie Pallister1*, Deborah Middleton1, Christopher C. Broder2 and Lin-Fa Wang1
1CSIRO Livestock Industries, Australian Animal Health Laboratory, 5 Portarlington Road, Geelong, VIC, 3220, Australia
2Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD 20814, USA
- *Corresponding Author:
- Jackie Pallister
CSIRO Livestock Industries
Australian Animal Health Laboratory
5 Portarlington Road,Geelong
VIC, 3220, Australia
Tel: 61 3 5227 5277
Fax: 61 3 52275555
E-mail: jackie.pallister@csiro.au
Received Date: July 16, 2010; Accepted Date: September 07, 2011; Published Date: September 25, 2011
Citation: Pallister J, Middleton D, Broder CC, Wang LF (2011) Henipavirus Vaccine Development. J Bioterr Biodef S1:005. doi: 10.4172/2157-2526.S1-005
Copyright: © 2011 Pallister J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
The henipaviruses, Hendra virus and Nipah virus, belong to the family Paramyxoviridae which has long been a source of highly contagious pathogens for both humans and animals. Some notable paramyxoviruses such as measles virus have spilled over from animals into humans to cause significant morbidity and mortality. Since 1994 the henipaviruses have periodically emerged from their animal reservoir in flying foxes to cause disease in human and animal populations. The recent emergence of these viruses coupled with the high mortality rate associated with henipavirus infections and the lack of any licensed prophylactic or therapeutic treatments, makes them agents of particular concern in the area of both human and agricultural biodefense. Advances in our understanding of henipavirus infection and pathogenesis has led to the development of several promising vaccine candidates making it likely that vaccines for henipavirus infections may be available in the near future.
